Measuring unanticipated opportunity costs of South Africa's COVID-19 response for children, mothers, and people living with non-communicable diseases
- Funded by Department for Business, Energy and Industrial Strategy, Foreign, Commonwealth & Development Office (FCDO), UK Research and Innovation (UKRI)
- Total publications:0 publications
Grant number: GB-GOV-13-FUND--GCRF-MR_V028537_1
Grant search
Key facts
Disease
COVID-19Start & end year
20202020Known Financial Commitments (USD)
$881,451.96Funder
Department for Business, Energy and Industrial Strategy, Foreign, Commonwealth & Development Office (FCDO), UK Research and Innovation (UKRI)Principal Investigator
N/A
Research Location
South AfricaLead Research Institution
WITS HEALTH CONSORTIUMResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Children (1 year to 12 years)Infants (1 month to 1 year)Newborns (birth to 1 month)
Vulnerable Population
Individuals with multimorbidity
Occupations of Interest
Unspecified
Abstract
MRC GECO COVID award to measure unanticipated opportunity costs of South Africa's COVID-19 response for children, mothers, and people living with non-communicable diseases COVID-19